NO965244L - Farmasöytisk preparat inneholdende en hydrofob aktivt substans og et brusesystem, og fremgangsmåte til fremstilling derav - Google Patents

Farmasöytisk preparat inneholdende en hydrofob aktivt substans og et brusesystem, og fremgangsmåte til fremstilling derav

Info

Publication number
NO965244L
NO965244L NO965244A NO965244A NO965244L NO 965244 L NO965244 L NO 965244L NO 965244 A NO965244 A NO 965244A NO 965244 A NO965244 A NO 965244A NO 965244 L NO965244 L NO 965244L
Authority
NO
Norway
Prior art keywords
hydrophobic active
pct
active substance
preparation
pharmaceutical composition
Prior art date
Application number
NO965244A
Other languages
English (en)
Other versions
NO965244D0 (no
NO314016B1 (no
Inventor
Gerhard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Publication of NO965244D0 publication Critical patent/NO965244D0/no
Publication of NO965244L publication Critical patent/NO965244L/no
Publication of NO314016B1 publication Critical patent/NO314016B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19965244A 1994-06-15 1996-12-09 Farmasöytisk preparat inneholdende en hydrofob aktiv substans og et brusesystem, og fremgangsmåte til fremstilling derav NO314016B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01890/94A CH686865A5 (de) 1994-06-15 1994-06-15 Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
PCT/EP1995/001904 WO1995034284A1 (de) 1994-06-15 1995-05-19 Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung

Publications (3)

Publication Number Publication Date
NO965244D0 NO965244D0 (no) 1996-12-09
NO965244L true NO965244L (no) 1997-02-13
NO314016B1 NO314016B1 (no) 2003-01-20

Family

ID=4221002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965244A NO314016B1 (no) 1994-06-15 1996-12-09 Farmasöytisk preparat inneholdende en hydrofob aktiv substans og et brusesystem, og fremgangsmåte til fremstilling derav

Country Status (26)

Country Link
US (1) US5834019A (no)
EP (1) EP0768868B1 (no)
JP (1) JPH10501535A (no)
KR (1) KR100367302B1 (no)
CN (1) CN1149071C (no)
AT (1) ATE204744T1 (no)
AU (1) AU684966B2 (no)
BR (1) BR9508002A (no)
CA (1) CA2191302C (no)
CH (1) CH686865A5 (no)
CO (1) CO4410175A1 (no)
CZ (1) CZ287807B6 (no)
DE (1) DE59509566D1 (no)
ES (1) ES2161901T3 (no)
HU (1) HU221680B1 (no)
IL (1) IL114144A (no)
MX (1) MX9606391A (no)
MY (1) MY113718A (no)
NO (1) NO314016B1 (no)
NZ (1) NZ288208A (no)
PE (1) PE42295A1 (no)
PL (1) PL180135B1 (no)
SK (1) SK281262B6 (no)
TW (1) TW457097B (no)
WO (1) WO1995034284A1 (no)
ZA (1) ZA954932B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
WO1998056364A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
CA2440935A1 (en) * 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
DK1392254T3 (da) * 2001-04-20 2007-07-02 Univ British Columbia Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
DK1435910T3 (da) * 2001-10-19 2009-11-09 Isotechnika Inc Nye cyclosporinanaloge mikroemulsionsprækoncentrater
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
CN100381123C (zh) * 2005-01-12 2008-04-16 南京亿华药业有限公司 一种氯雷他定颗粒剂及其制法
CN101897732B (zh) * 2009-05-27 2013-01-30 北京因科瑞斯医药科技有限公司 一种中药泡腾片剂及其制备方法
CN106236713B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种七清败毒泡腾颗粒及其制备方法
CN107296800A (zh) * 2017-06-01 2017-10-27 江苏黄河药业股份有限公司 一种氯雷他定泡腾片及其制备方法
CN112741841A (zh) * 2019-10-29 2021-05-04 湖北真奥医药研究院有限公司 三维钙自乳化泡腾剂组合物及其制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584522D1 (de) * 1984-12-14 1991-11-28 Gergely Gerhard Teilchen aus einer hydrophoben oder schwerloeslichen substanz und verfahren zu ihrer hydrophilisierung.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs

Also Published As

Publication number Publication date
US5834019A (en) 1998-11-10
CH686865A5 (de) 1996-07-31
AU684966B2 (en) 1998-01-08
TW457097B (en) 2001-10-01
WO1995034284A1 (de) 1995-12-21
PL180135B1 (pl) 2000-12-29
CZ367296A3 (en) 1997-04-16
CN1149071C (zh) 2004-05-12
ATE204744T1 (de) 2001-09-15
IL114144A (en) 1999-07-14
CN1151693A (zh) 1997-06-11
CA2191302A1 (en) 1995-12-21
KR970703131A (ko) 1997-07-03
CZ287807B6 (en) 2001-02-14
BR9508002A (pt) 2000-05-30
HU221680B1 (hu) 2002-12-28
PE42295A1 (es) 1995-12-28
SK159396A3 (en) 1997-08-06
ES2161901T3 (es) 2001-12-16
NO965244D0 (no) 1996-12-09
JPH10501535A (ja) 1998-02-10
EP0768868B1 (de) 2001-08-29
ZA954932B (en) 1996-02-07
AU2749795A (en) 1996-01-05
CA2191302C (en) 2010-08-10
MX9606391A (es) 1997-07-31
SK281262B6 (sk) 2001-01-18
KR100367302B1 (ko) 2003-04-16
NZ288208A (en) 1998-08-26
DE59509566D1 (de) 2001-10-04
NO314016B1 (no) 2003-01-20
HUT75674A (en) 1997-05-28
HU9603452D0 (en) 1997-02-28
IL114144A0 (en) 1995-10-31
EP0768868A1 (de) 1997-04-23
CO4410175A1 (es) 1997-01-09
PL317856A1 (en) 1997-04-28
MY113718A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
NO965244L (no) Farmasöytisk preparat inneholdende en hydrofob aktivt substans og et brusesystem, og fremgangsmåte til fremstilling derav
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
FR2771291B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
PT760649E (pt) Formulacoes a base de propionato de fluticasona
ATE183495T1 (de) 6-dimethylaminomethyl-1-phenyl-cyclo- hexanverbindungen als pharmazeutische wirkstoffe
ATE188961T1 (de) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1- olverbindungen als pharmazeutische wirkstoffe
DK0993830T3 (da) Nye stabiliserede galeniske formuleringer indeholdende en syrelabil benzimidazolforbindselse og fremgangsmåde til fremstilling heraf
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
DE69520768D1 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
EE200100660A (et) Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
ES2178154T3 (es) Proceso de preparacion de formas solidas de dosificacion farmaceutica.
ATE122882T1 (de) Antiphlogistisches mittel.
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
HRP940315A2 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
AU7623496A (en) Stable mixtures of incompatible active ingredients for plant protection
AU5145396A (en) Mechanically stable solid formulations of active substances
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
NO307460B1 (no) Optiske aktive forbindelser, fremgangsmõte for fremstilling derav, farmasøytisk blanding og anvendelse derav
IT1254938B (it) Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono